首页> 外国专利> MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS

MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS

机译:固醇对脂溶性药物的溶解度,稳定性,吸收,代谢和药代动力学特性的调节

摘要

A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of a lipophilic therapeutic agent by formulation with sterols and/or sterol esters, resulting in higher bioavailability of a therapeutic agent administered to a subject in need of such therapeutic agent. The formulation contains a therapeutic agent and a sterol or sterol ester, and can, optionally, further contain a solubilizer and/or an enhancing agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters.
机译:通过与固醇和/或固醇酯一起配制,提供了增强的亲脂性治疗剂的溶解度,稳定性,吸收,代谢和/或药代动力学特性的调节的药物递送制剂,从而导致给予受试者的治疗剂具有更高的生物利用度需要这种治疗剂。该制剂包含治疗剂和固醇或固醇酯,并且可以任选地进一步包含增溶剂和/或增强剂。还描述了包含制剂和制备方法的药物组合物以及使用该制剂和药物组合物的方法。当治疗剂包括睾丸激素或睾丸激素酯时,可以构成本公开的制剂以最小化二氢睾丸激素的合成。

著录项

  • 公开/公告号PL2519230T3

    专利类型

  • 公开/公告日2019-05-31

    原文格式PDF

  • 申请/专利权人 MARIUS PHARMACEUTICALS LLC;

    申请/专利号PL20100841783T

  • 发明设计人 DHINGRA OM;

    申请日2010-12-31

  • 分类号A61K9/48;A61K9;A61K9/107;A61K9/20;A61K9/22;A61K31/4985;A61K31/56;A61K31/568;A61K31/575;A61K45/06;A61P15;A61P15/10;

  • 国家 PL

  • 入库时间 2022-08-21 12:01:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号